REPL News and Press, Replimune Group Inc. From 07/30/25

A look at the top 10 most actives in the United States Healthcare Triangle Inc. (HCTI) fell 40.6% to $0.0302 on volume of 679,551,998 shares OceanPal Inc. (OP) rose 24.6% to $0.1749 on volume of 453,031,715 shares Incannex Healthcare Inc. (IXHL) fell 17.8% to $0.88 on volume of 414,920,824 ...

2025-07-30 14:43:59 ET More on Replimune Group Replimune: A Surprise CRL Exposes Fragility Of The Melanoma Program Replimune Group, Inc. (REPL) Q4 2025 Earnings Call Transcript Replimune Group: Analysts Are More Optimistic Than The Market Sarepta, Replimmune,...

2025-07-30 10:27:30 ET More on Sarepta, Capricor, etc. Sarepta Therapeutics: Beaten Down, But Not Out Replimune: A Surprise CRL Exposes Fragility Of The Melanoma Program Sarepta: Despite Restructuring, Downgrading To Sell After Latest Developments FDA vaccine...

A look at the top 10 most actives in the United States Healthcare Triangle Inc. (HCTI) fell 27.8% to $0.0367 on volume of 280,601,764 shares OceanPal Inc. (OP) rose 53.2% to $0.21505 on volume of 242,608,036 shares Incannex Healthcare Inc. (IXHL) rose 10.7% to $1.185 on volume of 123,637,30...

REPL Investors Have Opportunity to Lead Replimune Group, Inc. Securities Lawsuit First Filed by The Rosen Law Firm PR Newswire NEW YORK , July 29, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, announces it has filed ...

DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Replimune DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Replimune PR Newswire Faruqi & Faruqi, LLP Securities Litigation Partner James (J...

New York, New York--(Newsfile Corp. - July 27, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Replimune Group, Inc. (NASDAQ: REPL) and certain of the Company's senior executives for potential violations of the federal securit...

New York, New York--(Newsfile Corp. - July 25, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Replimune Group, Inc. (NASDAQ: REPL) for potential violations of the federal securities laws. If you invested in Replimune, you are encouraged to...

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Significant Losses In Replimune To Contact Him Directly To Discuss Their Options If you suffered significant losses in Replimune stock or options and would like to discuss ...

New York, New York--(Newsfile Corp. - July 23, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Replimune Group, Inc. (NASDAQ: REPL) for potential violations of the federal securities laws. If you invested in Replimune, you are encouraged to...